SRL
SYRE icon

Scientech Research LLC’s Spyre Therapeutics SYRE Stock Holding History

Scientech Research LLC’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,088
Closed -$358K – 525
2026
Q1 		$358K Buy
+7,088
New +$267K 0.3% 88
2024
Q2 		– Sell
-13,143
Closed -$499K – 739
2024
Q1 		$499K Buy
+13,143
New +$381K 0.26% 164

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Scientech Research LLC's SYRE Position: Q2 2026 in Review

Scientech Research LLC sold out of Spyre Therapeutics (SYRE) in Q2 2026, closing a stake of 7,088 shares — an estimated $358K sold.

Scientech Research LLC first reported a position in SYRE in Q1 2024 and held it in 2 quarters. The position peaked at $499K in Q1 2024. 265 funds tracked by Wall St. Rank hold SYRE as of Q2 2026.

  • Scientech Research LLC reported no remaining Spyre Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 7,088 Spyre Therapeutics shares in Q2 2026, an estimated $358K.
  • Scientech Research LLC first reported a position in Spyre Therapeutics in Q1 2024 and held it in 2 quarters.
  • Scientech Research LLC's Spyre Therapeutics position peaked at $499K in Q1 2024.
  • 265 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.